Kura Oncology share price logo

Kura Oncology

NASDAQ: KURA

Small Cap

$7.16

-0.46

(-5.98%)

Live

as on

Kura Oncology Stock Performance

as on November 6, 2026 at 4:46 am IST

  • Day's Low

    Day's High

    $6.98
    $7.70
    downward going graph

    2.51%

    Downside

    7.54%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $7.36
    $13.90
    downward going graph

    -2.76%

    Downside

    94.13%

    Upside

    downward going graph

Kura Oncology share price movements today

Previous Close
$7.61
Open
$7.60
Volume
1.3M
Market Cap
$878.9M
Day's Low - High
$6.98 - $7.70
52 Week Low - High
$7.36 - $13.90

Kura Oncology Historical Returns

1 Month Return
-28.34 %
3 Month Return
-17.28 %
1 Year Return
-23.44 %
3 Year Return
-15.54 %
5 Year Return
-61.11 %

Kura Oncology Stock Fundamentals & Key Indicators

Check Kura Oncology market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$878.9M

EPS (TTM)

-3.37

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.93

Industry PE ratio

-6.15

PEG Ratio

0.08

EBITDA

-294.4M

Revenue (TTM)

77.2M

Profit Margin

94.73%

Return On Equity TTM

-207.18%

Kura Oncology vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kura Oncology with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$878.9M-61.11%-2.9394.73%0.00%
Neutral$91.2B9.03%-28.63-12.57%0.00%
StrongBuy$141.7B192.56%32.2786.04%0.00%
Buy$99.4B52.18%20.7385.77%0.38%

Stock Returns calculator for Kura Oncology Stock including INR - Dollar returns

The Kura Oncology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kura Oncology investment value today

Current value as on today

₹76,846

Returns

-₹23,154

(-23.15%)

Returns from Kura Oncology Stock

-₹27,968 (-27.97%)

Dollar Impact

₹4,814 (+4.81%)

Analyst Recommendation on Kura Oncology Stock

Based on 6 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 6 analysts, 100% of analysts recommend a 'BUY' rating for Kura Oncology. Average target price of $31.85

Kura Oncology Share Price Target

Get share price movements and forecasts by analysts on Kura Oncology.

What analysts predicted

77.52%UPSIDE

Target Price

$31.85

Current Price

$7.16

Analyzed by

6 Analysts

High

$40

Target

$31.85

Low

$15

Kura Oncology target price $31.85, a slight upside of 77.52% compared to current price of $7.16. According to 6 analysts rating.

Indian Investors' Interest in Kura Oncology Stock

Search interest for Kura Oncology Stock has decreased by -69% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-69% versus previous 30 day period

Kura Oncology Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
53
14
15
20
17
18
20
Gross Profit
0
0
-
53
14
15
17
17
17
20
Operating Income
-54
-56
-59
-22
-64
-72
-79
-86
-78
-73
EBITDA
-48
-50
-53
-16
-57
-65
-73
-80
-72
-67
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-49
-50
-54
-17
-57
-66
-74
-80
-73
-68
Income Tax Expense
-
-
-
2
0
-
-
0
0
0
Net Income
-49
-50
-54
-19
-57
-66
-74
-80
-73
-68
Net Profit Margin
0.00%
0.00%
0.00%
100.00%
100.00%
100.00%
84.52%
100.00%
96.62%
98.84%

Kura Oncology Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
53
67
Gross Profit
0
0
-
0
-
-
0
53
67
Operating Income
-36
-62
-67
-91
-131
-139
-165
-193
-303
EBITDA
-36
-62
-67
-88
-129
-134
-150
-169
-275
Interest Expense
0
0
0
0
0
0
1
1
1
Depreciation
0
0
0
0
0
0
0
0
1
Income Before Tax
-35
-60
-63
-89
-130
-135
-152
-171
-278
Income Tax Expense
0
-
-
-
-
-
-
2
0
Net Income
-35
-60
-63
-89
-130
-135
-152
-173
-278
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
99.92%

Kura Oncology Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-49
-50
-54
-19
-57
-66
-74
-80
-73
-68
Operating Cash Flow
-48
-42
-43
269
-71
-28
-80
117
-85
-62
Investing Cash Flow
-95
43
45
-94
-101
58
93
-64
-24
92
Financing Cash Flow
148
3
2
0
0
0
-
1
0
1
Change in Cash
4
3
4
174
-173
30
13
53
-110
31

Kura Oncology Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-35
-60
-63
-89
-130
-135
-152
-173
-278
Operating Cash Flow
-28
-48
-54
-69
-104
-110
-124
134
-64
Investing Cash Flow
-23
-79
-46
-99
-126
32
15
-101
-13
Financing Cash Flow
53
132
111
469
-3
38
94
154
1
Change in Cash
1
4
10
299
-234
-38
-14
187
-75

Global Institutional Holdings in Kura Oncology

Check out the Institutions with significant holdings in Kura Oncology.

Funds
Holdings
BlackRock, Inc.
11.81%
Vanguard
5.20%
iShares
5.17%
VANGUARD INDEX FUNDS
4.30%
SPDR
3.38%

Kura Oncology News & Key Events

  • img

    Today's Timeline - 09 September

    Wed, 04:50 PM

    -

    Kura Oncology announces the launch of Caspian Therapeutics to advance menin inhibitors for diabetes and cardiometabolic diseases.

    Wed, 05:00 PM

    -

    Kura Oncology invests $4.3 million in Caspian Therapeutics, retaining 49.2% ownership and establishing a partnership for cardiometabolic programs.

Insights on Kura Oncology

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 996.7% return, outperforming this stock by 1020.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 233.3% return, outperforming this stock by 248.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, KURA stock has moved down by -27.9%

About Kura Oncology

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company’s first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
OrganisationKura Oncology
Headquarters4930 Directors Place, San Diego, CA, 92121, US
IndustryBiotechnology
CEOTroy Wilson

Key Management of Kura Oncology

Name

Title

Dr. Troy Edward Wilson J.D., Ph.D.

Chairman, CEO & President

Mr. Thomas Doyle

Senior Vice President of Finance & Accounting

Mr. Greg Mann

Senior Vice President of Investor Relations & Corporate Affairs

Dr. Roger Bakale Ph.D.

Senior Vice President of Manufacturing & Supply Chain

Dr. Mollie Leoni M.D.

Chief Medical Officer

Ms. Kathleen Ford

Chief Operating Officer

Mr. Brian T. Powl M.B.A., M.S.

Chief Commercial Officer

Ms. Jennifer Fulk

Chief Financial Officer

Dr. Francis J. Burrows Ph.D.

Chief Scientific Officer

Ms. Teresa Brophy Bair Esq., J.D.

Chief Legal Officer & Corporate Secretary

FAQs

What is Kura Oncology share price today?

Kura Oncology share price today is $7.16 as on . Kura Oncology share today touched a day high of $7.70 and a low of $6.98.

What is the 52 week high and 52 week low for Kura Oncology share?

Kura Oncology share touched a 52 week high of $13.90 on and a 52 week low of $7.36 on . Kura Oncology stock price today i.e. is trending at $7.16,which is 48.49% down from its 52 week high and -2.68% up from its 52 week low.

What is Kura Oncology's market capitalisation today?

Kura Oncology market capitalisation is $0.00T as on .

How to invest in Kura Oncology Stock (KURA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kura Oncology on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Kura Oncology Stock (KURA) from India?

Indian investors can start investing in Kura Oncology (KURA) shares with as little as ₹94.4749984741211 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in Kura Oncology stock (as per the Rupee-Dollar exchange rate as on ). Based on Kura Oncology share’s latest price of $7.16 as on November 5, 2026 at 11:16 pm IST, you will get 1.3966 shares of Kura Oncology. Learn more about fractional shares .

What are the returns that Kura Oncology has given to Indian investors in the last 5 years?

Kura Oncology stock has given -61.11% share price returns and 27.92% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?